Suven Pharmaceuticals announced the appointment of Vivek Sharma as its new Executive Chairman, effective September 20, 2024. This move follows the transition of Vaidheesh Annaswamy, who will now serve as Vice-Chair of Suven’s advisory council.
In a statement, the company said, “Vivek brings tremendous CDMO and leadership expertise to Suven, acquired across his roles as CEO of Piramal Pharma Solutions (2014-19) and as Chairman & CEO of Adare Pharma Solutions (2020-22).”
Sharma’s experience also includes being CEO of Decision Resources Group, a healthcare analytics firm, and AI clinical analytics company Saama. He was recognized as ‘Global CEO of the Year’ by CPhI Pharma Awards in 2015.
Suven highlighted that based out of Boston, Sharma will help strengthen customer connections and drive global expansion for the company. He holds an Executive MBA from Thunderbird School of Global Management and is both a Chartered Accountant and a Certified Public Accountant (CPA).
As of 9:19 AM, Suven Pharma shares were trading 2.50% higher at ₹1,208.85 on the NSE.
